Are there any recent changes in keytruda's price?

I don’t have real-time pricing data, and there hasn’t been any widely publicized, large-scale price drop for Keytruda (pembrolizumab) in major markets recently. However, drug prices can change quietly due to rebates, negotiated prices with payers, and new dosing schedules.

A few things that can affect the price you see:
- Country and local pricing or htA negotiations (UK, Canada, EU, US, etc. differ a lot).
- Whether you’re looking at the list price vs. the net price after discounts/rebates.
- Dosing schedule (Keytruda is given as 200 mg every 3 weeks or 400 mg every 6 weeks in newer regimens; price per cycle depends on dose and vial usage).
- Indication and payer-specific arrangements; some programs vary by indication.

If you’d like, I can look up current approximate prices for Keytruda in your country and specify whether I’m giving list price or typical out-of-pocket estimates. Tell me:
- Your country
- Whether you want list price, estimated net price, or patient out-of-pocket
- The dosing schedule you’re using (200 mg every 3 weeks or 400 mg every 6 weeks)

I can also point you to reliable price-check resources (manufacturer patient assistance pages, major pharmacy price trackers like GoodRx in the US, or local equivalents).